Case reveals the challenge of misclassifying rectal cancer as urothelial carcinoma, highlighting the need for integrated diagnostic approaches.
Rectal mucinous adenocarcinoma rarely invades the prostate and can mimic primary urothelial carcinoma, risking misclassification. A man in his late 60s presented with urosepsis, and transurethral resection of papillary prostatic fossa tissue was initially read as high-grade urothelial carcinoma with adenocarcinoma differentiation. Pelvic imaging showed a rectoprostatic mass, and multidisciplinary review of histology, immunohistochemistry, and molecular profiling confirmed colorectal origin. After total neoadjuvant therapy, the rectal primary achieved clinical complete response, but residual prostate-bed disease persisted along a fistulous tract, requiring close surveillance. This case highlights integrated diagnostic assessment and careful response evaluation. • Rectal cancer invading the prostate mimicked primary urothelial carcinoma. • Transurethral biopsy initially suggested a high-grade urothelial tumor. • Integrated imaging, pathology, immunohistochemistry, and molecular profiling established colorectal origin. • Surgically altered pelvic anatomy and rectoprostatic fistulous extension contributed to diagnostic complexity. • Neoadjuvant therapy achieved clinical complete response of the rectal primary, but persistent prostate-bed disease required close surveillance.
No takes yet. Share an insight, caveat, or question.
Homeniuk et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: